Thomas S. Levato

Thomas Levato is a partner in Goodwin’s capital markets practice. He has extensive experience representing investment banks, issuers and investors in capital markets transactions, including initial public offerings, follow-on public offerings, and private placements of equity, equity-linked and debt securities. His practice covers a wide range of industries including life sciences; technology; cannabis; retail and consumer goods; electronic vehicles; aerospace and defense; metals and mining; mineral exploration; oil exploration and production; financial services; cryptocurrency; casino and gaming; and business development companies.

Thomas is a market leader in alternative financing transactions, including Confidentially Marketed Public Offerings (CMPOs), Registered Direct Offerings (RDs), Private Investments in Public Equity (PIPEs) and At-the-Market Offerings (ATMs). Goodwin is consistently ranked as one of the most active law firms advising on these transactions.

Thomas advises investment banks including Barclays Capital; BMO Capital Markets; BofA Securities; BTIG; Canaccord Genuity; Cantor Fitzgerald; Citigroup; Goldman Sachs; Guggenheim Securities; Jefferies; JMP Securities; J.P. Morgan; Keefe, Bruyette & Woods; Leerink Partners; Morgan Stanley; Oppenheimer & Co.; Piper Sandler; Raymond James; RBC Capital Markets; Stifel; TD Cowen; Truist Securities; UBS Investment Bank; Wells Fargo Securities; and William Blair.

Thomas also advises public and private companies in general corporate and securities matters, including corporate governance, public company reporting, and stock exchange rules and requirements.

A representative list of Thomas’s recent capital markets transactions is set forth below:

• BofA Securities, Morgan Stanley and Goldman Sachs as underwriters in an equity offering for Goldman Sachs BDC, Inc.
• Jefferies, BofA Securities and TD Securities as underwriters in a debt offering for Tilray Brands, Inc.
• Stifel and Goldman Sachs as initial purchasers in a debt offering for Cutera, Inc.
• J.P. Morgan and Stifel as underwriters in the initial public offering for Renalytix AI plc
• Cowen and Stifel as underwriters in an equity offering for DZS Inc.
• BMO Capital Markets as underwriter in an equity offering for Nouveau Monde Graphite Inc.
• Raymond James as underwriter in an equity offering for VBI Vaccines Inc.
• Jefferies, Stifel and Wells Fargo Securities as underwriters in an equity offering for MEI Pharma, Inc.
• Citigroup, Guggenheim Securities and Barclays as underwriters in an equity offering for Arcturus Therapeutics Holdings Inc.
• Oppenheimer & Co. as underwriter in an equity offering for Venus Concept Inc.
• Keefe, Bruyette & Woods and Piper Sandler as underwriters in an equity offering for Republic First Bancorp, Inc.
• Canaccord Genuity and Cantor Fitzgerald as underwriters in an equity offering for Cardiol Therapeutics Inc.
• Goldman Sachs, BofA Securities, Cowen and Jefferies as underwriters in an equity offering for Immunomedics, Inc.
• Truist Securities and William Blair as underwriters in an equity offering for American Public Education, Inc.
• Canaccord Genuity as underwriter in the initial public offering for Laird Superfood, Inc.
• Merrill Lynch, Leerink and Stifel as underwriters in an equity offering for Zogenix, Inc.
• Roth Capital Partners as underwriter in the initial public offering for Genenta Science S.p.A.
• Merrill Lynch, Cowen, Canaccord Genuity and BTIG as underwriters in the initial public offering for TiGenix NV
• Leerink and Cowen as underwriters in the initial public offering for Bellerophon Therapeutics, Inc.
• Stifel and Piper Jaffray as underwriters in the initial public offering for Conatus Pharmaceuticals Inc.
• Piper Jaffray and Stifel as underwriters in the initial public offering for Innocoll AG
• Stifel and JMP Securities as underwriters in the initial public offering for Marinus Pharmaceuticals, Inc.
• J.P. Morgan and Morgan Stanley as underwriters in an equity offering for NPS Pharmaceuticals, Inc.
• Leerink and RBC Capital Markets as underwriters in an equity offering for Tekmira Pharmaceuticals Corporation
• Cowen, Evercore ISI and UBS Investment Bank as underwriters in an equity offering for Molecular Templates, Inc.

Thomas's extensive capital markets experience also includes the representation of both investment banks and issuers in equity capital markets transactions including for: HCI Group, Vicinity Motor Corp, Palatin Technologies, TMC the metals company, Cue Biopharma, Innovative Solutions and Support, Annovis Bio, Riley Exploration Permian, Faraday Future Intelligent Electric, Oryzon Genomics, Agrify Corp, Bird Global, Clene, Clever Leaves Holdings, Edesa Biotech, Enveric Biosciences, HEXO Corp, Hut 8 Mining, Inseego, ObsEva, Oncolytics Biotech, Plus Therapeutics, Spire Global, Sundial Growers, Patriot Financial, Motus GI Holdings, Femasys, Integra Resources, Hillevax, Kopin, Momentus, Arcimoto, Calyxt, Beyond Air, Verb Technology, Engine Media Holdings, Jushi Holdings, Oramed Pharmaceuticals, PowerFleet, Mind Medicine, AgEagle Aerial Systems, ElectraMeccanica Vehicles, 3D Systems, CorMedix, New York City REIT, Aphria, Aspen Group, Mohawk Group Holdings, RADA Electronic Industries, GenMark Diagnostics, Poxel SA, Aurinia Pharmaceuticals, ContraFect, Ocugen, 9 Meters Biopharma, Summit Therapeutics, Compugen and Novadaq Technologies.